Comprehensive Analysis Reveals Adaptive DNA Repair and Replication Stress Networks in Genomically Unstable Breast Cancer
Panday, A.; Ramadan, F.; Zahraeifard, S.; Subedi, U.; Shah, S.; Yadav, N.
Show abstract
Genomic instability is a defining hallmark of breast cancer, yet the mechanisms by which tumors tolerate persistent DNA damage remain poorly understood. We performed a comprehensive, multi-cohort analysis of breast cancer datasets to define how DNA damage response (DDR) and replication stress tolerance (RST) networks are rewired in genomically unstable tumors. Using fraction of genome altered (FGA) as a chromosomal instability metric, we show that BRCA-mutant tumors exhibit elevated genomic instability coupled with increased expression of homologous recombination, Fanconi anemia, mismatch repair, base excision repair, and alternative end-joining pathways. Strikingly, heightened pathway activity correlates with increased genome alteration, supporting a model of damage tolerance rather than repair restoration. RST programs, including fork remodeling, protection, and single strand DNA gap suppression, further contribute to tumor fitness under replication stress. These adaptive states are enriched in aggressive subtypes, intensified with progression, and associate with pathway-specific mutational burden. Co-occurrence and mutual exclusivity mapping uncovered non-random subtype-relevant genetic interactions states among major drivers and DDR genes, nominating context-specific synthetic lethal opportunities. Our findings identify compensatory genome-maintenance programs as central drivers of tumor resilience and highlight pathway-specific vulnerabilities for targeted therapeutic intervention.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A recurrent pathogenic BRCA2 truncating variant reveals a role for BRCA2-PCAF complex in modulating NF-κB-driven transcription 97%
- Multiplexed RNA-FISH-guided Laser Capture Microdissection RNA Sequencing Improves Breast Cancer Molecular Subtyping, Prognostic Classification, and Predicts Response to Antibody Drug Conjugates 96%
- Epigenetic control of Topoisomerase 1 activity presents a cancer vulnerability 95%
Similar papers in this journal
- CIP2A interacts with TopBP1 and is selectively essential for DNA damage-induced basal-like breast cancer tumorigenesis 97%
- Aberrant transcript usage induces homologous recombination deficiency and predicts therapeutic responses 96%
- Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression and drug response 95%
Similar papers in this journal
- Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages 96%
- Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome 96%
- Cell cycle alterations associate with a redistribution of mutation rates across chromosomal domains in human cancers 95%
Similar papers in this journal
- Evolution of chromosome arm aberrations in breast cancer through genetic network rewiring 97%
- Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors 95%
- Genome-wide identification and analysis of prognostic features in human cancers 95%
Similar papers in this journal
- Integrative multi-omic sequencing reveals the MMTV-Myc mouse model mimics human breast cancer heterogeneity 97%
- Mutational landscape of pure ductal carcinoma in situ and associations with disease prognosis and response to radiotherapy 96%
- Acquired mutations and transcriptional remodeling in long-term estrogen-deprived locoregional breast cancer recurrences 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.